Navigation Links
January 2009 - Rahu Appoints David Greensmith to Non Executive Directo
Date:2/2/2009

NOTTINGHAM, England, February 2 /PRNewswire/ --

- With Photo

David has enjoyed a long and highly successful career in the global chemical sector including Managing Director Fujifilm, Chief Operating Officer of Avecia, and as one of the three directors leading Zeneca Specialty Chemicals into private ownership. David's more than 30 years experience also includes significant M&A work, knowledge of key Rahu markets and, of course, new business development.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081219/332497-a )

David holds a number of other non executive positions including Chairman of One Central Park, Chairman Liverpool Associates in Tropical Health, Chairman of MatOx Ltd and Non Exec Director of the Warwick International Group Ltd.

Commenting on the appointment, Rahu CEO Paul Smith recognised David's wealth of experience and industry network and added "Rahu is moving to a new phase in its development and David's guiding hand will be pivotal in ensuring we deliver on our plans to create growth and value."

In response, David welcomed the exciting challenge presented by Rahu Catalytics, commenting "I am delighted to be joining the Board of Rahu at this early stage in the development of the business with its high growth potential. Rahu's strong patent positions and the multiple application areas the Executive team have already developed with strong industry partners give me confidence of a bright future for the business."

Note to Editors:

A picture accompanying this release is available through the PA Photowire. It can be downloaded from http://www.pa-mediapoint.press.net or viewed at http://www.mediapoint.press.net or
'/>"/>

SOURCE Rahu Catalytics Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cordex Pharma Presents New Frontiers in Cardiovascular Medicines on January 29
2. Abaxis to Report Third Quarter Fiscal 2009 Financial Results Thursday, January 29, 2009
3. TechConnect World 2009 Announces January 28th Last Call for Speaker-Proposals
4. InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13
5. OpenClinica to Present at International Conference on Health Informatics, January 14-17, Porto, Portugal
6. Interim Report for the Period 1 January - 30 September 2008 (Unaudited)
7. Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited)
8. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
9. Bioponic Phytoceuticals Announces Record Sales Increase of 40% for the Month of January
10. ProMetic provides business update - Over $35 million worth of business secured in January
11. January Market Jitters Fails to Derail Biotech
Post Your Comments:
*Name:
*Comment:
*Email: